Sadatsafavi M - Search Results

1

A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease.

Zafari Z, Bryan S, Sin DD, Conte T, Khakban R, Sadatsafavi M. Zafari Z, et al. Among authors: sadatsafavi m. Value Health. 2017 Jan;20(1):152-162. doi: 10.1016/j.jval.2016.08.003. Epub 2016 Oct 10. Value Health. 2017. PMID: 28212957 Free article. Review.

2

Cost-effectiveness of LTBI treatment for TB contacts in British Columbia.

Tan MC, Marra CA, Sadatsafavi M, Marra F, Morán-Mendoza O, Moadebi S, Elwood RK, FitzGerald JM. Tan MC, et al. Among authors: sadatsafavi m. Value Health. 2008 Sep-Oct;11(5):842-52. doi: 10.1111/j.1524-4733.2008.00334.x. Epub 2008 Jul 15. Value Health. 2008. PMID: 18489519 Free article.

3

An ounce of prevention is worth a pound of cure: a cost-effectiveness analysis of incidentally detected aneurysms in functional MRI research.

Sadatsafavi M, Marra C, Li D, Illes J. Sadatsafavi M, et al. Value Health. 2010 Sep-Oct;13(6):761-9. doi: 10.1111/j.1524-4733.2010.00755.x. Epub 2010 Jun 17. Value Health. 2010. PMID: 20561317 Free PMC article.

4

Economic and humanistic burden of external genital warts.

Raymakers AJ, Sadatsafavi M, Marra F, Marra CA. Raymakers AJ, et al. Among authors: sadatsafavi m. Pharmacoeconomics. 2012 Jan;30(1):1-16. doi: 10.2165/11591170-000000000-00000. Pharmacoeconomics. 2012. PMID: 22201520 Review.

5

Response to 'Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research', Jackson et al., Journal of Health Services Research & Policy 2011;16:141-6.

Bolbocean C, Regier DA, Bansback N, Sadatsafavi M, Whitehurst DG, Bryan S. Bolbocean C, et al. Among authors: sadatsafavi m. J Health Serv Res Policy. 2012 Apr;17(2):127. doi: 10.1258/jhsrp.2012.012007. J Health Serv Res Policy. 2012. PMID: 22535902 No abstract available.

6

Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.

Sadatsafavi M, Marra C, Bryan S. Sadatsafavi M, et al. Health Econ. 2013 Jul;22(7):877-82. doi: 10.1002/hec.2869. Epub 2012 Aug 30. Health Econ. 2013. PMID: 22933363

7

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.

Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, Sin D. Najafzadeh M, et al. Among authors: sadatsafavi m. PLoS One. 2012;7(10):e46746. doi: 10.1371/journal.pone.0046746. Epub 2012 Oct 11. PLoS One. 2012. PMID: 23071626 Free PMC article.

8

A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.

Sadatsafavi M, Marra C, Marra F, Moran O, FitzGerald JM, Lynd L. Sadatsafavi M, et al. Value Health. 2013 Jan-Feb;16(1):66-75. doi: 10.1016/j.jval.2012.09.006. Value Health. 2013. PMID: 23337217 Free article.

9

Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.

Sadatsafavi M, Bansback N, Zafari Z, Najafzadeh M, Marra C. Sadatsafavi M, et al. Value Health. 2013 Mar-Apr;16(2):438-48. doi: 10.1016/j.jval.2012.10.018. Epub 2013 Jan 26. Value Health. 2013. PMID: 23538197 Free article.

10

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD.

Thorlund K, Zafari Z, Druyts E, Mills EJ, Sadatsafavi M. Thorlund K, et al. Among authors: sadatsafavi m. Cost Eff Resour Alloc. 2014 Mar 13;12(1):8. doi: 10.1186/1478-7547-12-8. Cost Eff Resour Alloc. 2014. PMID: 24625208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page